Found: 5
Select item for more details and to access through your institution.
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV‐1 in need of parenteral antiretroviral therapy.
- Published in:
- HIV Medicine, 2023, v. 24, n. 2, p. 202, doi. 10.1111/hiv.13370
- By:
- Publication type:
- Article
2497. Women's Perspectives on and Experiences with Long-acting Injectable Anti-retroviral Therapy in the United States and Spain: the Potential Role of Gender in Patient Preferences.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S866, doi. 10.1093/ofid/ofz360.2175
- By:
- Publication type:
- Article
Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2017, v. 41, n. 5, p. 601, doi. 10.7399/fh.10808
- By:
- Publication type:
- Article
Outcomes for participants during long-term follow-up after discontinuation of cabotegravir + rilpivirine long-acting in the phase III/IIIB clinical trials.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S306
- By:
- Publication type:
- Article